Skip to Content
MilliporeSigma

Key Documents

View All Documentation

B1680

Bradyzide di(trifluoroacetate) salt hydrate

≥98%

Synonym(s):

(S)-1-[4-(4-Benzhydrylthiosemicarbazido)-3-nitrobenzenesulfonyl]-pyrrolidine-2-carboxylic acid [2-[(2-dimethylaminoethyl)methylamino]ethyl] amide

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C32H42N8O5S2 · 2C2HF3O2 · xH2O
Molecular Weight:
910.90 (anhydrous basis)
UNSPSC Code:
41106200
NACRES:
NA.32
MDL number:
MFCD02684401
Assay:
≥98%
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Segment

100

assay

≥98%

form

solid

solubility

H2O: >40 mg/mL

storage temp.

−20°C

Biochem/physiol Actions

Potent, orally active, non-peptide B2 bradykinin receptor antagonist.

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library